Individuals on immunosuppressants should discontinue them prior to patch testing, if at all possible, to avoid tarnishing the test results, according to updated guidelines from the North American ...

(NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for ...

Cold weather, dry air, an overactive immune system or our modern lifestyle. The causes may vary, but an increasing number of ...

The FDA has granted Fast Track designation to rezpegaldesleukin for the treatment of moderate to severe atopic dermatitis.

Patients with mild atopic dermatitis who reported nighttime scratching experienced relief when they used an artificial intelligence (AI)-powered wearable sensor that delivered haptic feedback on sleep ...

Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...

More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.

To access the live and archived webcast, visit the News & Events page of the company's website at . The archived webcast will be available for 30 days following the presentation.

Janus kinase inhibitors are an incredibly important, new tool that have exemplified both high efficacy and safety, according to a speaker at South Beach Symposium.In an interview with Healio, ...

Your indoor versus outdoor environment could have an even bigger impact on your eczema symptoms than you realize.

Experts warn air pollution could be making your eczema worse, but there are simple ways you can help protect your skin.

Dermatology, Sibel's advanced wearable sensor coupled with biofeedback led to a 40% decrease in duration of nighttime scratching in atopic dermatitis patients Sibel Health and Maruho sign a ...